The retinoic acid (RA) receptor b isoform (RARb) plays an important role in RA-induced dierentiation of human neuroblastoma. In this study we show that insulin-like growth factor 1 (IGF-1) and tetradecanoyl phorbol acetate (TPA) induce RARb gene expression in neuroblastoma SH-SY5Y cells. IGF-1 and TPA caused a marked induction of RARb2 promoter activity and had a synergistic eect with RA that also upregulates transcription. The eect of RA is mediated by two RA responsive elements (RAREs), whereas the IGF-1 and TPA actions are independent of the RAREs and map to sequences that overlap the TATA box. These results suggest that the signaling pathways stimulated by TPA and IGF-1 could modify the components assembled at the core RARb2 promoter and activate transcription.
Introduction
Neuroblastoma is a common childhood tumor of neuroectodermal origin with a high rate of spontaneous regression. These tumor cells provide an excellent model system to analyse the mechanisms that revert tumorigenicity and induce neuronal dierentiation. Neuroblatoma cell lines can be induced to dierentiate by several agents (Thiele, 1991) . Dierentiation of neuroblastoma cells, which is characterized by the appearance of long neurites and changes in the expression of several marker genes, is accompanied by arrest of tumor cells growth. Among the agents that induce neuroblastoma cell dierentiation retinoic acid (RA) appears to be quite potent (Haussler et al., 1983) . This has led to clinical trials of retinoids to treat neuroblastoma and other neoplastic diseases (Gudas et al., 1994; Villablanca et al., 1995) . Phorbol esters, which activate protein kinase C and act as tumor promoters in other cell types also promote dierentiation of neuroblastoma cells as judged by morphology and expression of neuronal markers (Bjelfman et al., 1990; Pahlman et al., 1991) . On the other hand, insulin-like growth factor 1 (IGF-1), which is a mitogen for some undierentiated neuroblastoma cells, shifts from promoting cell division to potentiating maturation during neuroblastoma cell dierentiation (Pahlman et al., 1991; Sumantran and Feldman, 1993) . The actions of IGF-1 are mediated by tyrosine kinase receptors. The Ras proto-oncogene is one of the intracellular eectors of tyrosine kinase receptors. Ligand activation of these receptors leads to activation of Ras and of the serine/threonine kinase Raf which acts downstream of Ras in the signaling pathway (LeRoith et al., 1995) .
The eects of RA are mediated by nuclear receptors (RARs) which belong to the subfamily of nonsteroid hormone receptors (Mangelsdorf and Evans, 1995) . These receptors normally act as ligand-inducible transcription factors by binding to cis-acting responsive elements (RA responsive elements or RAREs) which are normally located in the regulatory region of target genes. RAREs typically consist of at least two copies of the consensus sequence PuG G / T TCA, that can be con®gured into a variety of motifs. Data from several laboratories have shown that the most potent RAREs are con®gured as direct repeats (DRs) separated by 2 or 5 nucleotides (DR2 and DR5, respectively) (Glass, 1994) . As opposed to receptors for steroid hormones that bind to DNA as homodimers, RAR preferentially binds DNA as a heterodimer with the retinoid X receptor (RXR). Since DRs are inherently assymetric, heterodimers may bind to them with two distinct polarities. Indeed, it has now been established that on the RARE, RXR occupies the 5' half-site and the heterodimeric partner (e.g. RAR) occupies the 3' half-site (Zechel et al., 1994) . This particular arrangement permits RAR, upon ligand binding, to undergo conformational changes which facilitate the recruitment of a coactivator complex. This multisubunit complex contains factors with histone acetylase activity, which allows chromatin remodeling and creates a permissive state for promoter activation (Torchia et al., 1998) .
RARs are encoded by three dierent genes (a, b and g) which give rise to dierent isoforms (Glass, 1994) . While RARa is ubiquitously expressed, RARb and RARg expression is more restricted (Ruberte et al., 1991) . Although some degree of redundancy among the dierent isoforms has been observed in knockout mice (Kastner et al., 1995) , the dierent receptor isoforms might have distinct biological functions. It has been described that neuroblastoma primary tumor tissue and cell lines express RARa, and to a lesser degree RARg. RARb is expressed at a very low level, but is strongly induced by treatment with RA (Lovat et al., 1993; Redfern et al., 1994; Carpentier et al., 1997) . In neuroblastoma cells transfected with RARs, only RARb transfectants exhibited marked growth inhibition and neuritogenic eects (Cheung et al., 1996) . Therefore, the induction of RARb is thought to play an important role in the morphological dierentiation as well as in the arrest of neuroblastoma cell growth. The important role of this isoform has been con®rmed in recent studies in which the eects of receptor-selective retinoids on neuroblastoma cells have been analysed (Giannini et al., 1997; Lovat et al., 1997; Irving et al., 1998) .
The promoter of the RARb2 isoform is strongly activated by RA in undierentiated embryonal carcinoma (EC) cells. The human promoter contains a strong DR5-type RARE (bRARE) located at nucleotides 737 to 753 with respect to transcription initiation (De TheÂ et al., 1990; Sucov et al., 1990) . More recent studies have suggested the existence of a weaker RARE at positions 767 to 783 (Sanguedolce et al., 1997) . The close proximity of the RAREs to the TATA box and the Initiator (Inr) sequence rather than the arrangement of these elements appears to be crucial to establish productive interactions of the receptor heterodimers with neighboring components of the basal transcriptional machinery (Sanguedolce et al., 1997) . Additional regulatory elements have been also described to be involved in RARb2 promoter activation. Thus, a putative tetradecanoyl phorbol acetate (TPA)-responsive element (TRE) at position 778 to 784 overlapping the distal RARE, and a cAMP-responsive element (CRE) at position 792 to 799 adjacent to that element have been described to be involved in RAdependent RARb2 promoter activation in EC cells (Kruyt et al., 1992; Dey et al., 1994) .
In this study we report that a common feature of RA, TPA and IGF-1-induced dierentiation of neuroblastoma cells is induction of RARb gene transcription. IGF-1 and TPA induce RARb transcripts, as well as RARb2 promoter activation in the neuroblastoma cell line SH-SY5Y. These agents also potentiate RA-dependent induction of the RARb gene. The eect of TPA is PKC and Ras-dependent, whereas IGF-1 stimulates promoter activity by a mechanism independent of PKC but dependent of the Ras/MAPK signaling pathway. A full induction by RA requires both RAREs present in the promoter, but stimulation by TPA and IGF-1 is independent of the RAREs and also of the putative TRE. Furthermore, both agents induced activity of a construct which contains only the 737 to +14 promoter fragment. These sequences do not contain binding sites for known transcription factors and are composed essentially of the TATA box and the Inr. Deletion of the Inr does not impair regulation by IGF-1 or TPA, suggesting that an eect on components of the basal transcriptional machinery is responsible for stimulation by these factors. In agreement with this hypothesis, the amount of complexes bound to this sequence increased in IGF-1-and TPA-treated SH-SY5Y cells.
Results

Induction of RARb2 mRNA by RA in SH-SY5Y
We have analysed induction of RARb transcripts by RA in neuroblastoma SH-SY5Y cells, a clonal derivative of SK-N-SH cells which consists solely of (Lovat et al., 1993; Redfern et al., 1994; Carpentier et al., 1997) , RA produced a strong induction of this mRNA (Figure 1) . The time-course of the response to 1 mM RA is shown in Figure 1a . The increase of RARb mRNA was observed within 4 h of incubation with RA, reaching a maximum after 24 h and remaining elevated for at least 96 h. The right panel (Figure 1b) shows that the induction of RARb transcripts was dose-dependent and was detectable at a low dose of RA (10 nM).
Function of the RAREs on activation of the RARb2 promoter by RA in SH-SY-5Y cells
In order to analyse the eect of RA on RARb promoter activity, the construct R140-CAT containing the human RARb2 promoter was transfected into SH-SY5Y cells. Figure 2b shows that treatment with 1 mM RA for 24 or 48 h increased promoter activity by approximately eightfold in these cells. In order to determine the relative contribution of the elements present in this promoter fragment to RA-dependent transcription, CAT reporters driven by the RARb2 promoter that contain mutations in these elements were constructed ( Figure 2a ). As shown in Figure 2c , mutation of the 3' or 5' hemisites of the proximal RARE (R140m3-CAT and R140m7-CAT, respectively) reduced reporter activation by approximately 70% but did not totally abolish the response to RA. A plasmid containing a shorter promoter fragment (R90-CAT) in which the distal RARE, as well as the putative CRE and TRE elements have been deleted, also showed a reduced activation. In addition, deletion of the distal RARE together with mutations in the proximal RARE (R90m3-CAT and R90m7-CAT constructs) completely abrogated RA-dependent activation. These results indicate that the proximal RARE is the main element responsible for transactivation of the RARb2 promoter and that the distal sequences are required for a full response to RA in SH-SY5Y cells. 
RARE-binding activity in vitro
The induction of RARb gene expression should result in increased binding of RXR/RAR heterodimers to the RAREs upon RA treatment. To analyse in vitro occupancy of these elements, gel retardation assays were performed with nuclear extracts from SH-SY5Y cells using 32 P-labeled distal and proximal RAREs as probes. As seen in Figure 3 , extracts from both untreated cells and cells treated with 1 mM RA for 48 h produced the appearance of several retarded bands with both probes. These bands were speci®c since they were competed in the presence of an excess of the corresponding unlabeled oligonucleotide (lanes 1 ± 5). Similarly, lanes 12 ± 14 show that both RAREs are bound by recombinant RXR/RAR heterodimers. The presence of RARb and RXR in the retarded complexes was analysed by incubation with antibodies against both receptors. Lanes 8 and 9 demonstrate that the complexes formed with extracts from untreated and RA-treated cells were partially super-shifted in the presence of an anti-RXR antibody (a-RXR), demonstrating that the binding activity contains this receptor both before and after RA treatment. In contrast, an anti-RARb antibody (a-RARb) did not cause supershift of the complexes from control cells (lane 10). This indicates the absence of this receptor isoform in signi®cant amounts previous to RA induction. Stimulation of RARb gene expression by RA produces RARb binding to the RAREs as demonstrated by the appearance of a super-shifted band with a-RARb (lane 8).
TPA and IGF-1 cooperate with RA to induce RARb gene expression
Since the induction of RARb appears to play an important role in neuroblastoma cell growth and dierentiation, we tested the possibility that nonretinoid compounds which aect these processes could also increase RARb gene expression. It had been shown that SH-SY5Y cells cease to proliferate and undergo neuronal dierentiation when exposed to nanomolar concentrations of phorbol esters (Bjelfman et al., 1990) . The representative experiment illustrated in Figure 4a shows that incubation with 100 nM TPA for 30 h increased RARb mRNA levels and was able to enhance signi®cantly the transcriptional response to RA in SH-SY5Y cells. Similar results were obtained in several independent experiments in which TPA increased by 3 ± 4-fold RA-dependent stimulation. It has been reported earlier that IGF-1 can cause some neurite extension and potentiate morphological differentiation induced by phorbol esters (Pahlman et al., 1991; Sumantran and Feldman, 1993) . As shown in Figure 4b , incubation of SH-SY5Y cells with 5 nM IGF-1 for 30 h also increased RA-mediated induction of RARb transcripts. In contrast to the results obtained with TPA, RARb mRNA levels remained below detection levels in cells incubated with IGF-1 alone, although in three dierent experiments IGF-1 increased by about twofold the response to RA.
In order to analyse whether the induction of RARb gene expression caused by TPA and IGF-1 was accompanied by changes in the formation of retarded complexes with the proximal RARE, gel retardation assays were performed with nuclear extracts from SH-SY5Y cells treated with these agents in the presence and absence of RA. Figure 4c shows that treatment with TPA or IGF-1 did not cause the appearance of new retarded bands but augmented the intensity of the complexes. Furthermore, both compounds potentiated the eect of RA. Similar results were obtained with the distal RARE (not illustrated).
Activation of the RARb2 promoter by IGF-1 and TPA
The possibility that the actions of these agents on RARb gene expression were exerted at the transcriptional level was tested by transient transfection assays with the CAT reporters illustrated in Figure 2a . Figure  5a shows that TPA and IGF-1 increased the activity of the R140-CAT construct by approximately ®ve-and fourfold, respectively. Furthermore, and in agreement with the induction of RARb mRNA levels, the combination of TPA+RA or IGF-1+RA had a synergistic eect and increased RARb2 promoter activity by almost 20-fold. Deletion of the sequences 7124 to 759 which contain the distal RARE and the putative TRE did not decrease promoter activity by TPA or IGF-1, showing that these elements do not participate in activation by these compounds. The eect of TPA and IGF-1 is also independent of the proximal RARE, since activation of the construct R90m3-CAT by TPA and IGF-1 was almost identical to that found with R90-CAT. However, mutation of the proximal RARE in R90 abolished induction by RA and also the synergistic activation. To further map the sequences responsible for stimulation by TPA and IGF-1, an additional reporter plasmid with a further 5' deletion (R37-CAT) was also transfected. The only known elements in this promoter fragment are the TATA box and the initiator. This construct was not activated by RA, but it still retained inducibility by TPA and IGF-1. It has been reported that the initiator could play a role in transactivation of the RARb2 promoter in P19 EC cells (Dey et al., 1994) . To analyse a possible role of this element in the observed responses, SH-SY5Y cells were transfected with the reporter plasmid R90DInr-CAT. In this construct the sequences comprised between nucleotides 723 and +14 that include the initiator have been deleted. As illustrated in Figure 5a , the response of the construct R90DInr-CAT to RA was similar to that found with R90-CAT. Furthermore, both TPA and IGF-1 were able to stimulate the activity of this construct and to increase RA-dependent transactivation.
The above results indicate that the sequences between 737 and 723 which contain essentially the TATA box could mediate regulation by IGF-1 and TPA. To test whether they could alter assembly of basal transcription factors to the TATA box, we conducted gel retardation assays in 1.4% agarose gels in the presence of 5 mM Mg
2+
. This technique is appropriate for resolving the very large protein-DNA complexes of interest (Lieberman and Berk, 1994) . Figure 5b shows that under these conditions nuclear extracts from control SH-SY-5Y cells formed a retarded band with the sequences 737 to +14 of the RARb2 promoter. The mobility of the retarded complex was not altered in extracts from cells incubated with TPA or IGF-1, but these treatments caused a signi®cant increase in the amount of complexes formed. This result suggests that both compounds could in¯uence directly the concentration and/or activity of components of the basal transcriptional machinery responsible for RARb gene transcription.
As IGF-1 enhances TPA-induced dierentiation of SH-SY5Y cells, the in¯uence of the combination of TPA+IGF71 on RARb2 promoter activity was also examined. In the experiment illustrated in Figure 5c , TPA increased promoter activity by eightfold, IGF-1 by fourfold, and the combination of both caused a 15-fold induction. These results show that in the absence of RA both compounds can have a cooperative eect on RARb gene expression. However, TPA caused a maximal stimulation in the presence of RA (more than 40-fold), and this activity was not further induced in cells treated also with IGF-1.
Signaling pathways involved in the stimulation of the RARb2 promoter by TPA and IGF-1
The involvement of protein kinase C (PKC) in the stimulation of the RARb2 promoter was analysed by using the speci®c inhibitor GF109203X (bisindolylma- Figure 6a illustrates the eect of 24 h incubation with TPA, IGF-1 and/or RA in the presence or absence of 2 mM GF109203X on R140-CAT activity. The inhibitor blocked the eect of TPA, and in its presence CAT activity was similar in cells treated with TPA+RA and with RA alone. This eect was speci®c because stimulation by IGF-1 was unaected. The concentration of TPA (100 nM) as well as the exposure times used in the present studies are sucient to cause depletion of PKC in several cell types. If this was the case in SH-SY5Y cells, the responses to TPA under these conditions should be inhibited. However, in this cell type, micromolar concentrations of phorbol esters appear to be required to cause PKC down-regulation. As shown in Figure 6b , PKC depletion caused by preincubation of SH-SY5Y cells for 48 h with 2 mM TPA before transfection completely abolished its own ability to induce RARb2 promoter activity, as well as its synergistic eect with RA. In contrast, depletion of PKC did not alter the responses to RA and IGF-1 either alone or in combination. These results show that the stimulatory eect of TPA on the RARb2 promoter is dependent on PKC activity, whereas the action of IGF-1 and RA are PKC-independent.
It is well known that the Ras/Raf/MAPK signaling pathway is the main eector of tyrosine kinase receptors (Su and Karin, 1996) and that this pathway can also mediate dierent eects of PKCs (Kolch et al., 1993) . If this pathway was involved in activation of the RARb2 promoter, expression of activated Ras should stimulate the promoter and cooperate with RA. Indeed, as shown in Figure 7a , cotransfection of the R140-CAT with an expression vector for oncogenic Ras Val12 increased CAT activity by 3 ± 4-fold and acted synergistically with RA. The induction in RA-treated cells expressing Ras Val12 was very strong (almost 40-fold). Interestingly, Ras Val12 caused a further induction of CAT activity in cells incubated with TPA or IGF-1, but was not able to stimulate further the values obtained with the combination of these agents and RA.
To con®rm the role of endogenous Ras and Raf on the actions of TPA and IGF-1, the cells were transfected with expression vectors encoding dominant negative versions of these oncogenes. As illustrated in Figure 7b , the Ras ASN17 mutant which inhibits the activity of wild-type endogenous Ras did not aect regulation by RA, but reduced very signi®cantly TPAand IGF-1-dependent stimulation of the RARb2 promoter in the SH-SY5Y cells. Promoter activity in cells treated with the combination of TPA or IGF-1 with RA returned to the levels found in cells treated with RA alone when the endogenous Ras was inactivated. Similar results were obtained with the dominant inhibitory Raf mutant. Therefore, TPA and IGF-1 activate the RARb2 promoter via a Ras-and Raf-dependent mechanism. In contrast, regulation by RA is independent of this pathway.
Activation of the IGF-1 receptor causes the recruitment and activation of phosphatidyl inositol 3-kinase (PI-3 kinase), and this enzyme can be a direct target of Ras (Rodriguez-Viciana et al., 1994) . However PI-3 kinase is not involved in IGF-1-dependent activation of the RARb2 promoter, since incubation with 100 nM Wortmannin, a strong and speci®c inhibitor of PI-3 kinase, did not in¯uence the response to IGF-1 in SH-SY5Y cells (data not shown). On the other hand, Okadaic acid (OA), a potent inhibitor of serine/threonine phosphoprotein phosphatases 1 and 2A, can enhance the expression of genes which are inducible by phorbol esters or ligands of tyrosine kinase receptors (Schonthal, 1992) . Figure 7c shows the in¯uence of incubation with 10 nM OA on the response of R140-CAT to RA, TPA, IGF-1. OA by itself had little eect on RARb2 promoter activity, but signi®cantly increased induction by these agents either in combination or separately.
Discussion
RARs may play a key role in mediating neurite outgrowth and growth arrest in neuroblastoma cells. Among the RAR isoforms, RARb appears to be important in mediating the eects of RA in these cells. In agreement with previous studies (Lovat et al., 1993 , Redfern et al., 1994 Carpentier et al., 1997) , we have found that RA increases RARb transcripts in the neuroblastoma cell line SH-SY5Y. RARb gene expression in dierent cell types is controlled by two promoters (Zelent et al., 1989) . The promoter that regulates the expression of RARb2 is strongly induced by RA, whereas RARb1 and RARb3 are induced to a much lesser extent (De TheÂ et al., 1990; Sucov et al., 1990) . Our work shows that RA-induced dierentiation of SH-SY5Y cells is preceded by a marked increase in the activity of the RARb2 promoter. This induction is mediated by the proximal RARE located in the proximity of the TATA box. In addition a more upstream positioned promoter fragment contributes to the activation of the promoter by RA. This fragment contains a recently identi®ed RARE which overlaps with a previously described putative TRE (Sanguedolce et al., 1997) . A CRE-related element is also present in this promoter segment and it has been shown that forskolin, which stimulates adenylate cyclase activity, was able to enhance RARb2 promoter activation by RA in kidney 293 cells (Kruyt et al., 1992) . In contrast, incubation with forskolin neither increases basal RARb2 promoter activity nor enhances the response to RA in SH-SY5Y cells, showing that this element does not play a role in RA-dependent transcription in this cell type (PeÂ rez-Juste and Aranda, unpublished results).
Our results also show that treatment of SH-SY5Y cells with RA increases the abundance of RARb which bind to both RAREs. RARb binds as a heterodimer with RXR to these elements. RARb is not detected in the complexes from control cells but it is a component of the nuclear extracts after RA treatment. Nuclear extracts from SH-SY5Y cells produce the appearance of several retarded bands with the RAREs, and these bands are not totally supershifted in the presence of anti-RXR or anti-RARb antibodies. This demonstrates that other receptors and/or transcription factors contribute to the protein-DNA complexes formed with the RAREs. Although we have not attempted to identify the dierent components involved, the heterodimers RXR/RARa or RXR/RARg, which are constitutively expressed in SH-SY5Y cells, should be present in the complexes from the untreated cells (Carpentier et al., 1997) . These RAR isoforms would be responsible for the initiation of the response to RA in SH-SY5Y cells, and the autoregulatory loop leading to RARb expression should amplify the retinoidinduced regulatory signal.
Our work stresses the importance of RARb expression in neuroblastoma by showing that neuronal dierentiation induced by non-retinoid agents such as TPA or IGF-1 is also accompanied by increased transcription of the RARb gene. However, this does not prove that this induction is responsible for the dierentiating actions of these compounds. Both agents play an important role in nervous system, differentiation and function. Although they induce growth of many cell types, these factors can act as dierentiating agents in SH-SY5Y cells as judged by morphology, reduction of c-myc mRNA levels and expression of neuronal markers (Pahlman et al., 1991; Sumantran and Feldman, 1993) . Both TPA and IGF-1 increase the amount of RARb transcripts in the presence of RA and the activity of the RARb2 promoter. However, there is a discrepancy between the potency of these compounds to increase RARb mRNA and RARb2 promoter activation, since both agents are similarly eective to increase promoter activity, whereas TPA was more eective than IGF-1 inducing RARb. The reasons for this discrepancy are presently unclear. The presence of a TRE (a TPA-responsive element) in the RARb2 promoter suggested that the phorbol ester could stimulate RARb gene expression through this DNA element. However, mapping of the elements responsible for promoter activation demonstrated that the TRE does not mediate stimulation by TPA and might be a non-functional element. Moreover, both the distal and proximal RAREs are dispensable for TPAand IGF-1-dependent promoter activation. In fact sequences comprised between 737 and +14 confer full promoter responsiveness to both agents, a responsiveness which is not aected either by deletion of the initiator-containing sequences 723 to +14. These results predict that proteins interacting in the vicinity of the TATA box, by inference components of the basal transcriptional machinery, play an important regulatory role in activation by TPA and IGF-1. There are several indications that transcriptional responses can be mediated through sequences centered around the TATA box (Wefald et al., 1990; Leitman et al., 1992, Desmarais and Royal, 1996) , although the mechanisms underlying this type of regulation are presently unclear. That IGF-1 and TPA could facilitate the assembly of a functional preinitiation complex is suggested by the ®nding that these agents increase the amount of complexes bound to RARb2 promoter sequences containing the TATA box. The TATAbinding protein (TBP) can associate with a variety of TBP-associated factors (TAFs) and transcriptional activators (Hampsey and Reinberg, 1997) . It is then possible that the signaling pathways stimulated by TPA and IGF-1 could modify the components assembled at the core RARb2 promoter and activate transcription. Elucidation of the molecular basis for this regulation will require a ®ne analysis of the molecules associated with the transcription initiation complex.
Our results show that PKC activity is required for TPA-dependent transcription of the RARb gene. It has been shown that PKCa is the isoform expressed in SH-SY5Y cells, and that this enzyme remains functionally active after long-term treatment with concentrations of TPA that induce neuronal dierentiation. Very high concentrations of TPA appear to be required to cause complete down-regulation of PKCa in SH-SY5Y cells (Parrow et al., 1992) and, in agreement with this observation, preincubation with micromolar concentrations of TPA abrogates activation of the RARb2 promoter by the phorbol ester. PKC is an important point of intersection of dierent signal transduction pathways since many cellular receptors for extracellular chemical messengers can activate PKC (Nishizuka, 1995) . Among them, receptors that have tyrosine kinase activity and activate Ras can also activate PKC (Pawson, 1992) . However, PKC is not involved in RARb gene expression by IGF-1 in SH-SY5Y cells. In contrast the Ras/Raf/MAPK pathway is involved in the response to both IGF-1 and TPA. Our data show that expression of activated Ras mimics the eect of both compounds and synergizes strongly with RA to stimulate the promoter. Furthermore, expression of a dominant inhibitory mutant of Ras blocks the induction of RARb2 promoter stimulation in response to TPA and IGF-1, as well as the synergism with RA.
These results show the requirement of functional Ras for these responses. In addition a dominant inhibitory Raf also inhibited the eect of IGF-1 and TPA, demonstrating that endogenous Raf kinase is also required and showing that IGF-1 and TPA activate RARb gene expression through a Ras-Raf dependent signal transduction in SH-SY5Y cells. The serine/ threonine phosphatase inhibitor OA enhances stimulation by TPA and IGF-1 and also by RA. Dierent nuclear receptors, including RARs can be phosphorylated (Weigel, 1996) and phosphorylation of RARa and RARg by CDK7 and protein kinase A stimulates transactivation by RA in a promoter context dependent manner and plays a role in EC cell dierentiation Taneja et al., 1997) . Thus, there was the possibility that the actions of PKC and Ras on transactivation of the RARb2 promoter by RA in neuroblastoma cells could be mediated by receptor phosphorylation. However, the ®nding that IGF-1 and TPA can activate the promoter in the absence of RAREs suggests that their actions are mediated by phosphorylation of other proteins. The identity of these molecules remains to be established.
SH-SY5Y cells can be considered as representing a clonal strain of neuroblastoma at an immature stage of dierentiation. Our results show that stimulation of PKC or Ras/MAPK which elicit an arrest in cell growth and promote maturation in these cells converges with the actions of retinoids to activate RARb gene transcription providing an example of cross talk among dierent signaling pathways. An inhibition of expression of N-myc in cells with this oncogene ampli®ed (Thiele et al., 1985) , or the induction of TrkB, a tyrosine kinase receptor known to be important in neuron survival and dierentiation, may be some of the mechanisms by which RA subsequently causes neuroblastoma cell maturation (Kaplan et al., 1993; Nakagawara et al., 1994) . Retinoids have proven to be of clinical use in the treatment of dierent tumors. Our observations that TPA and IGF-1 increase RA sensitivity can provide valuable directions for the development of new strategies that can be exploited for the treatment of neuroblastoma tumors.
Materials and methods
Plasmids
R140-CAT construct containing the fragment 7124 to +14 of the human RARb2 promoter was obtained from the previously described R140-Luc (14). The promoter fragment was obtained by PCR with the oligonucleotides 5'-GGGAAGCTTGGATCCTGGGAGTTGGT-3' and 5'GCT-CTAGAGCTCACTTCCTACTAC-3' and subcloned in HindIII and XbaI sites of pBLCAT8+ (which lacks the AP-1 element present in the plasmid backbone), replacing the thymidine kinase (tk) promoter. The same strategy was used to obtain R140m3 and R140m7 from the parental constructs (Vivanco-Ruiz et al., 1991) . In these plasmids the 3' (m3) and 5' (m7) half-sites of the proximal RARE have been mutated. In the construct R90-CAT the fragment from 759 to +14 of the RARb2 promoter, obtained by PCR with the oligonucleotides 5'-GGGAAGCTTGGGAAGGGTTCACCGAA-3' and 5'-GCTCTAGAGCTCACTTCCTACTAC-3', was similarly cloned into the HindIII/XbaI sites of pBLCAT8+. The mutant R90m7 was constructed using the R90m7 luciferase construct as template and R90m3 was constructed using as 5' primer the mutated primer 5'-GGGAAGCTTGGGAA-GAACTCACCGAAA-3'. The plasmid R37-CAT containing nucleotides 737 to +14 of the promoter was also obtained by PCR using as the 5' primer 5'-GGGAAGCTTGCATA-TATTAGGCAATTC-3'. In the construct R90DInr-CAT that includes the sequences from 757 to 723, the initiator sequence was deleted using as the 3' primer 5'-CGCTCTA-GAGAATTGCCTAATATATGC-3'. Constitutive expression vectors for Ras Val12 , Ras Asn17 , and a dominant negative Raf lacking the catalytic domain (CaleÂ s et al., 1998; Feig and Cooper, 1988; Kolch et al., 1993) under control of the Rous Sarcoma virus (RSV) promoter have been previously described.
Cell culture, transient transfections and CAT assays SH-SY5Y cells were cultured in RPMI containing 10% fetal calf serum and plated 24 h prior to transfection into 60 mm dishes. The cells were then shifted to DMEM containing 10% AGX100 resin-charcoal treated newborn calf serum and transfected with calcium phosphate with 5 mg of the reporter plasmid plus 1 mg of a luciferase internal control plasmid). In co-transfection experiments the reporter plasmids were transfected with expression vectors for the Ras or Raf mutants. In all cases the total amount of DNA among dierent transfections was kept constant by addition of an empty noncoding expression vector. After 16 h of incubation the precipitates were washed and the treatments with RA (1 mM), IGF-1 (5 nM) and TPA (100 nM) were administered in RPMI containing 10% resin-charcoal treated new born calf serum. After 48 h CAT activity was determined by incubation of the cell extracts with [
14 C] chloramphenicol. The unreacted and acetylated [ 14 C] chloramphenicol were separated by thin layer chromatography and quanti®ed with an Instantimager. Each treatment with the ligands was performed at least in duplicate cultures that normally exhibited less than 10% variation in CAT activity, and the experiments were repeated at least two or three times with similar relative dierences in regulated expression. The results are expressed as the mean+standard deviation (s.d.) of the CAT values obtained.
Gel retardation assays
Nuclear extracts of SH-SY5Y prepared following the method of Andrews and Faller were used for gel retardation assays with the oligonucleotides 5'-GGGTAG-GGTTCACC-GAAAGTTCACTCG-3' corresponding to the proximal RARE of the RARb2 promoter and 5'-TGG-TTGGGTCATTTGAAGGTTAGCAGC-3' corresponding to the distal RARE. For the binding reaction, the nuclear extracts (10 mg) or recombinant RARa and RXRa (200 ng) were incubated at room temperature for 15 min at 48C in a buer (10 mM HEPES-(KOH) (pH 7.9), 80 mM KCl, 1 mM dithiothreitol, 5% Ficoll) containing 3 mg poly (dl-dC) and then for 30 min at room temperature with approximately 30 000 d.p.m. of labeled double stranded oligonucleotide endlabeled with 32 P-ATP. For competition experiments an excess of unlabeled double-stranded oligonucleotides were added to the binding reactions. For supershift experiments, 1 ml of speci®c antibodies against RXR (which recognizes the dierent receptor isoforms) and RARb were added to the binding reactions and incubated on ice for 30 min before the addition of the labeled probe. Finally, DNA-protein complexes were resolved on 6% polyacrylamide gels in 0.56 Tris-Borate-EDTA buer. The gels were then ®xed, dried and autoradiographed at 7708C.
For agarose gel mobility shift assays, 5 mg of nuclear extracts were incubated 15 min at 48C in 10 mM HEPES-(KOH) (pH 7.9), 80 mM KCl, 5 nM MgCl 2 , 1 mM dithiothreitol, 5% Ficoll, containing 3 mg poly (dG-dC) and then for 30 min at room temperature with approximately 50 000 c.p.m. of labeled probe corresponding to the nucleotides 737 to +14 of the RARb2 promoter. DNAprotein complexes were resolved on 1.4% agarose gels in 0.56 Tris-Borate-EDTA buer and 5 mM magnesium acetate.
RNA extraction and hybridization
Total RNA was extracted from cell cultures with guanidine thiocyanate. The RNA (30 mg) was run in 1% formaldehydeagarose gels and transferred to nylon-nitrocellulose membranes (Nytran) for Northern blot analysis. The RNA was stained with 0.02% methylene blue, and the blots were hybridized with a cDNA probe for RARb labeled by random oligonucleotide priming. Membranes were prehybridized for 10 min at 658C with 7% SDS, 500 nM phosphate buer pH 5.2 and 1 mM EDTA. Hybridizations were carried out for at least 16 h at 658C, and then the ®lters were washed for 30 min at 658C in the presence of 1% SDS. Quanti®cation of mRNA levels was carried out by densitometric scan of the autoradiograms. The values obtained were always corrected for the amount of RNA applied in each lane which was determined by the densitometry of the methylene blue stained membranes.
